A2T (p.Ala2Thr) variant of ATL1 (Atlastin-1)
A2T (p.Ala2Thr) in ATL1 (Atlastin-1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
A2T (p.Ala2Thr) variant details
- p.Ala2Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available